Myocardin is a potent transcriptional coactivator whose dysregulation is associated with diseases including heart failure, cancer, acute vessel disease, and diabetes.
Myocardin (MYOCD) is a potent transcriptional coactivator that functions primarily in cardiac muscle and smooth muscle through direct contacts with serum response factor (SRF) over cis elements known as CArG boxes found near a number of genes encoding for contractile, ion channel, cytoskeletal, and calcium handling proteins. Since its discovery more than 10 years ago, new insights have been obtained regarding the diverse isoforms of MYOCD expressed in cells as well as the regulation of MYOCD expression and activity through transcriptional, post-transcriptional, and post-translational processes. Curiously, there are a number of functions associated with MYOCD that appear to be independent of contractile gene expression and the CArG-SRF nucleoprotein complex. Further, perturbations in MYOCD gene expression are associated with an increasing number of diseases including heart failure, cancer, acute vessel disease, and diabetes. This review summarizes the various biological and pathological processes associated with MYOCD and offers perspectives to several challenges and future directions for further study of this formidable transcriptional coactivator.
Joseph M. Miano (Fri,) conducted a review in Myocardin-associated diseases (heart failure, cancer, acute vessel disease, diabetes). Myocardin (MYOCD) was evaluated. Myocardin is a potent transcriptional coactivator whose dysregulation is associated with diseases including heart failure, cancer, acute vessel disease, and diabetes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: